How could the prolonged precycle administration of aromatase inhibitors affect the in vitro fertilization and embryo transfer (IVF-ET) outcomes of patients with endometriosis?

Graziella Moufawad, G. Lamblin, Zaki Sleiman, Charles-Andre Philip
In: The Hormonal Treatment of Endometriosis and Adenomyosis · 2026 · pp. 241–247 · doi:10.1016/b978-0-443-27757-3.00022-5 · W7223317167
OA: closed CC0
Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".
View at publisher → View on OpenAlex
⚙ AI-generated summary by qwen3.7-flash, 2026-10-25 ⓘ

The provided text is a title-only entry lacking an abstract or results, making it impossible to summarize the study's findings regarding aromatase inhibitor effects on IVF-ET outcomes in endometriosis patients.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

References (27)

Source provenance

openalex
last seen: 2026-11-06T06:06:51.996266+00:00
unpaywall
last seen: 2026-11-06T06:34:47.334260+00:00
License: CC0 · commercial use OK